Pharma: Other News To Note
Friday, July 12, 2013
Galen US Inc., of Souderton, Pa., will acquire exclusive rights to market and sell Synera patch from Nuvo Research Inc., of Mississauga, Ontario, in the U.S. Sunera combines lidocaine, tetracaine and heat, and is approved by the FDA for local dermal analgesia.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.